LIXT Q4 2024 Earnings Biotech Reports Net Loss Stock Declines RPT Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Environment ARQT Q1 2026 Earnings EPS Miss Amid Biotech Sector Headwinds PubMatic Q1 2026 Earnings EPS Beats Estimates Shares Inch Higher BETR Q1 2026 Earnings Wide EPS Miss Sends Shares Lower Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus